Prosecution Insights
Last updated: April 19, 2026

Clark+Elbing LLP - 10X Genomics, Inc.

10 pending office actions • 1 client

Portfolio Summary

10
Total Pending OAs
1
Final Rejections
9
Non-Final OAs

Client Portfolio (1 client)

Client (Assignee)Pending OAs
10X Genomics, Inc. 10

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18427317 DEVICES AND METHODS FOR GENERATING AND RECOVERING DROPLETS 10X Genomics, Inc. BORTOLI, JONATHAN 1797 Non-Final OA Jan 30, 2024
18373002 DEVICES, METHODS, AND SYSTEMS FOR IMPROVED DROPLET RECOVERY 10X Genomics, Inc. KRCHA, MATTHEW D 1796 Non-Final OA Sep 26, 2023
18132115 SYSTEMS WITH A GASKET AND METHODS FOR ANALYZING SAMPLES 10X Genomics, Inc. MUI, CHRISTINE T 1797 Non-Final OA Apr 07, 2023
18131159 SYSTEMS AND METHODS FOR LIQUID DEPOSITION 10X Genomics, Inc. BORTOLI, JONATHAN 1797 Non-Final OA Apr 05, 2023
18131223 BLISTER PACKS AND USES THEREOF 10X Genomics, Inc. IMPINK, MOLLIE LLEWELLYN 3799 Non-Final OA Apr 05, 2023
18177935 PARTITION PROCESSING METHODS AND SYSTEMS 10X Genomics, Inc. BUNKER, AMY M 1684 Non-Final OA Mar 03, 2023
18177562 FLOW FOCUSING DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION 10X Genomics, Inc. CHIU, MAY LEUNG 1758 Non-Final OA Mar 02, 2023
18177504 DEVICES, SYSTEMS, AND METHODS FOR HIGH THROUGHPUT DROPLET FORMATION 10X Genomics, Inc. NGUYEN, HENRY H 1758 Non-Final OA Mar 02, 2023
18175885 DEVICES AND METHODS FOR FLOW CELL ASSEMBLY AND DISASSEMBLY 10X Genomics, Inc. HYUN, PAUL SANG HWA 1796 Non-Final OA Feb 28, 2023
18154516 DEVICES, SYSTEMS, AND METHODS FOR DIRECTING FLUID FLOW 10X Genomics, Inc. TURK, NEIL N 1798 Final Rejection Jan 13, 2023

Managing Clark+Elbing LLP - 10X Genomics, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month